Eris Lifesciences Ltd vs Strides Pharma Science Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of ERIS Lifesciences Ltd is ₹ 1357 as of 05 May 15:30 . The P/E Ratio of ERIS Lifesciences Ltd changed from 23.1 on March 2021 to 54.8 on March 2025 . This represents a CAGR of 18.86% over 5 yearsThe P/E Ratio of Strides Pharma Science Ltd changed from 28.2 on March 2021 to 1.7 on March 2025 . This represents a CAGR of -42.98% over 5 years The Market Cap of ERIS Lifesciences Ltd changed from ₹ 8207 crore on March 2021 to ₹ 19287 crore on March 2025 . This represents a CAGR of 18.64% over 5 yearsThe Market Cap of Strides Pharma Science Ltd changed from ₹ 7573 crore on March 2021 to ₹ 6165 crore on March 2025 . This represents a CAGR of -4.03% over 5 years The revenue of ERIS Lifesciences Ltd for the Dec '25 is ₹ 807.59 crore as compare to the Sep '25 revenue of ₹ 795.5 crore. This represent the growth of 1.52% The revenue of Strides Pharma Science Ltd for the Dec '25 is ₹ 1301 crore as compare to the Sep '25 revenue of ₹ 1247 crore. This represent the growth of 4.29% The ebitda of ERIS Lifesciences Ltd for the Dec '25 is ₹ 264.51 crore as compare to the Sep '25 ebitda of ₹ 291.3 crore. This represent the decline of -9.2% The ebitda of Strides Pharma Science Ltd for the Dec '25 is ₹ 339.48 crore as compare to the Sep '25 ebitda of ₹ 248.89 crore. This represent the growth of 36.4% The net profit of ERIS Lifesciences Ltd changed from ₹ 89.55 crore to ₹ 108.83 crore over 7 quarters. This represents a CAGR of 11.79% The net profit of Strides Pharma Science Ltd changed from ₹ 3349 crore to ₹ 208.12 crore over 7 quarters. This represents a CAGR of -79.56% The Dividend Payout of ERIS Lifesciences Ltd changed from 21.3 % on March 2021 to 129.35 % on March 2025 . This represents a CAGR of 43.44% over 5 yearsThe Dividend Payout of Strides Pharma Science Ltd changed from 28.66 % on March 2021 to 1.28 % on March 2025 . This represents a CAGR of -46.30% over 5 years .

About ERIS Lifesciences Ltd

Eris Lifesciences Limited was incorporated on January 25, 2007.
Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007.
Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on February 2, 2017.
The Company has a manufacturing plant in Guwahati, Assam and is presently engaged in manufacturing and marketing of pharmaceutical products.
It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors. The company develops, manufactures and commercializes branded pharmaceutical products in selected therapeutic areas within chronic and acute categories of the Indian Pharmaceutical Market (IPM), such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infective.

About Strides Pharma Science Ltd

Strides Pharma Science Limited was originally incorporated under the name 'Strides Arcolab Limited ' on June 28, 1990.
In FY 2016, Shasun Pharmaceuticals Limited merged with Strides Arcolab Limited forming a new identity 'Strides Shasun Limited', making it effective from 19 November, 2015 and name of the Company was changed to 'Strides Pharma Science Limited' from 'Strides Shasun Limited' effective on July 18, 2018. Strides Pharma Science is a global pharmaceutical company headquartered in Bengaluru, India.
The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic.
It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals.
Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids.

FAQs for the comparison of ERIS Lifesciences Ltd and Strides Pharma Science Ltd

Which company has a larger market capitalization, ERIS Lifesciences Ltd or Strides Pharma Science Ltd?

Market cap of ERIS Lifesciences Ltd is 18,813 Cr while Market cap of Strides Pharma Science Ltd is 9,680 Cr

What are the key factors driving the stock performance of ERIS Lifesciences Ltd and Strides Pharma Science Ltd?

The stock performance of ERIS Lifesciences Ltd and Strides Pharma Science Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for ERIS Lifesciences Ltd and Strides Pharma Science Ltd?

As of May 5, 2026, the ERIS Lifesciences Ltd stock price is INR ₹1357.95. On the other hand, Strides Pharma Science Ltd stock price is INR ₹1050.3.

How do dividend payouts of ERIS Lifesciences Ltd and Strides Pharma Science Ltd compare?

To compare the dividend payouts of ERIS Lifesciences Ltd and Strides Pharma Science Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.